racemetirosine has been researched along with Injuries, Radiation in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Samnick, S | 1 |
| Bader, JB | 1 |
| Hellwig, D | 1 |
| Moringlane, JR | 1 |
| Alexander, C | 1 |
| Romeike, BF | 1 |
| Feiden, W | 1 |
| Kirsch, CM | 1 |
1 trial available for racemetirosine and Injuries, Radiation
| Article | Year |
|---|---|
Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up.
Topics: Adult; alpha-Methyltyrosine; Brain Neoplasms; Diagnosis, Differential; Enzyme Inhibitors; Female; Gl | 2002 |